Related Experiment Video
Updated: Aug 16, 2025

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Cryptococcal meningitis in apparently immunocompetent patients
1Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China.
Abstract:
Cryptococcal meningitis (CM) is an invasive fungal disease that currently poses a threat to human health worldwide, with high morbidity and mortality, particularly in immunocompromised patients. Although CM mainly occurs in HIV-positive patients and other immunocompromised patients, it is also increasingly seen in seemingly immunocompetent hosts. The clinical characteristics of CM between immunocompromised and immunocompetent populations are different. However, few studies have focussed on CM in immunocompetent individuals. This review summarizes the clinical characteristics of apparently immunocompetent CM patients in terms of aetiology, immune pathogenesis, clinical presentation, laboratory data, imaging findings, treatment strategies and prognosis. It is of great significance to further understand the disease characteristics of CM, explore new treatment strategies and improve the prognosis of CM in immunocompetent individuals.
Insights
Cryptococcal meningitis (CM) affects immunocompromised individuals but is increasingly seen in immunocompetent hosts. This review details CM in immunocompetent patients, aiding understanding and treatment.
Area of Science:
- Infectious Diseases
- Mycology
- Immunology
Background:
- Cryptococcal meningitis (CM) is a life-threatening fungal infection.
- CM predominantly affects immunocompromised individuals, especially those with HIV.
- An increasing incidence of CM is observed in immunocompetent hosts.
Approach:
- This review synthesizes current knowledge on CM in immunocompetent individuals.
- It examines aetiology, immune pathogenesis, clinical presentation, diagnostics, and treatment.
- Prognosis and disease characteristics in this population are specifically addressed.
Key Points:
- Clinical features of CM differ between immunocompromised and immunocompetent patients.
- Limited research exists on CM in immunocompetent individuals.
- Understanding these differences is crucial for effective management.
Conclusions:
- Further research into CM in immunocompetent hosts is essential.
- Identifying unique characteristics can lead to improved diagnostic and therapeutic strategies.
- Enhanced understanding will improve patient outcomes and prognosis.
Related Concept Videos
Fungal Phylum Microsporidia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

